Literature DB >> 11246787

Cost analysis of dialysis modalities in Italy.

F Tediosi1, G Bertolini, F Parazzini, G Mecca, L Garattini.   

Abstract

This study analyses management and costs of dialysis in the Italian National Health Service (NHS). Information on efficacy and health-related quality of life (HRQOL) based on the existing literature also is presented. The clinical differences between the dialysis modalities seem to be related to their appropriateness to specific patient groups. Efficacy rates are similar and the only differences are in complications and HRQOL. Traditional haemodialysis (THD) can be done by Italian patients in dialysis centres or in hospital. Highflux haemodialysis (HFHD) is generally only done in hospital. Peritoneal dialysis (PD) is usually done at home. The cost analysis was performed on a sample of Italian dialysis centres and hospitals, according to the full cost method. As expected, HFHD was more expensive than THD and PD, but no marked differences emerged among the different HFHD modalities. THD modalities in dialysis centres were less costly than in hospitals. Automated PD (APD) was much more expensive (almost twice) than continuous ambulatory PD (CAPD), the cheapest method in absolute terms. This study confirms that dialysis is costly and that it is very difficult to assess the cost-effectiveness of the different approaches. Although this study has limits, it should provide sufficient analytical information to local healthcare managers for more rational allocation of financial resources to dialysis services.

Entities:  

Mesh:

Year:  2001        PMID: 11246787     DOI: 10.1177/095148480101400102

Source DB:  PubMed          Journal:  Health Serv Manage Res        ISSN: 0951-4848


  6 in total

Review 1.  The Impact of Chronic Kidney Disease on Nutritional Status and Its Possible Relation with Oral Diseases.

Authors:  Micaela Costacurta; Michele Basilicata; Giulia Marrone; Manuela Di Lauro; Vincenzo Campolattano; Patrizio Bollero; Raffaella Docimo; Nicola Di Daniele; Annalisa Noce
Journal:  Nutrients       Date:  2022-05-10       Impact factor: 6.706

2.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

3.  Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Jose M Abad; Nuria Aresté; Ramón Alonso de la Torre; Fergus Caskey; Cécile Couchoud; Patrik Finne; James Heaf; Andries Hoitsma; Johan de Meester; Julio Pascual; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

4.  The costs in provision of haemodialysis in a developing country: a multi-centered study.

Authors:  Priyanga Ranasinghe; Yashasvi S Perera; Mohamed F M Makarim; Aruna Wijesinghe; Kamani Wanigasuriya
Journal:  BMC Nephrol       Date:  2011-09-06       Impact factor: 2.388

5.  Economic evaluation of end stage renal disease patients undergoing hemodialysis.

Authors:  A Suja; R Anju; V Anju; J Neethu; P Peeyush; R Saraswathy
Journal:  J Pharm Bioallied Sci       Date:  2012-04

6.  Three years evaluation of peritoneal dialysis and hemodialysis absorption costing: perspective of the service provider compared to funds transfers from the public and private healthcare systems.

Authors:  Alyne Schreider; Celso Souza de Moraes Júnior; Natália Maria da Silva Fernandes
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.